# Phase I Clinical Trial to Evaluate the Safety and Tolerability of Ophtalmic Solution PRO-201

> **NCT05470881** · PHASE1 · COMPLETED · sponsor: **Laboratorios Sophia S.A de C.V.** · enrollment: 29 (actual)

## Conditions studied

- Myopia

## Interventions

- **DRUG:** Atropine Sulfate

## Key facts

- **NCT ID:** NCT05470881
- **Lead sponsor:** Laboratorios Sophia S.A de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-20
- **Primary completion:** 2022-12-26
- **Final completion:** 2022-12-26
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05470881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05470881, "Phase I Clinical Trial to Evaluate the Safety and Tolerability of Ophtalmic Solution PRO-201". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT05470881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*